Physician profile
Vincent A Catallozzi
NPI 1174528699
$666.46
in general payments reported to CMS, 2019-2025
13 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $18.35 · 2021: $51.48 · 2022: $39.34 · 2023: $66.33 · 2024: $81.83 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.82 | 2025 | |
| Sumitomo Pharma America, INC. | $118.32 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $116.90 | 2019 | |
| Astellas Pharma US INC | $66.03 | 2019-2021 | |
| Antares Pharma, INC. | $37.32 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Halozyme INC | $29.97 | 2023 | |
| Urovant Sciences INC | $23.99 | 2021 | |
| Immunitybio, INC. | $23.81 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.53 | 2025 | |
| Dendreon Pharmaceuticals LLC | $22.69 | 2025 | Provenge |
| Agiliti Surgical, INC. | $20.18 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Endocare Cryocare Cs System |
| Coloplast Corp | $18.35 | 2020 | |
| Medtronic, INC. | $17.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Catallozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.